Rare diseases
Investigational molecules
Locations
Dornhofstrasse 10, 63263 Neu-Isenburg, Germany
GBG Forschungs GmbH focuses on clinical research in breast cancer, with particular attention to HER2-negative disease and patients at elevated risk of relapse after standard neoadjuvant treatment. Its work includes studies in early-stage and high-risk settings, where treatment strategies are aimed at improving disease control and reducing recurrence.
The sponsor’s research activity also extends to invasive disease-free survival and pathological complete response as key clinical endpoints in early breast cancer.
GBG Forschungs GmbH runs clinical trials in conditions such as Breast cancer, Breast cancer metastatic, Invasive lobular breast carcinoma, Triple negative breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyGermany
Belgium
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
